Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair and restore hearing. By combining recent innovations in hearing science with leading diagnostic tools, biological insights, modeling and therapeutic delivery techniques, Decibel is pioneering a comprehensive approach to define the underlying biological causes of hearing loss and develop a pipeline of breakthrough drugs targeted to specific indications and patients.
Crunchbase Investment Rounds
|Date||Amount||Round||Valuation||Lead Investor||Other Investors|
|2018-06-19||$55,000,000||Series C||Bessemer Venture Partners, Schroder Adveq, Foresite Capital, GV, Third Rock Ventures, The Longevity Fund, SR One|
|2015-10-15||$52,000,000||Series A||Third Rock Ventures||GlaxoSmithKline, SR One|